PriceWatch Alerts

Free Stock Alerts
Every trading day, InvestorsObserver analysts prove our members with trade ideas, research, and analysis.
Check your email and confirm your membership to get information just like these alerts and all 100% Free!

Salix Pharmaceuticals (NASDAQ: SLXP) has been identified by InvestorsObserver analysts as being well-positioned for a new covered call today. Buying the stock for $84.00 while selling the March $75.00 call will produce a new covered call with a break-even point around $71.70. At that price, this position has a target return of 4.6 %. This trade will have roughly 14.6 % downside protection, while still aiming for a 4.6 % return in 131 days. It will lock in that return as long as Salix Pharmaceuticals is above $75.00 on 3/22/2014. For comparison purposes only, this SLXP covered call aims for an annualized return rate of 12.8 %.

Endo Pharmaceuticals (NASDAQ: ENDP) has been selected by InvestorsObserver analysts as a stock that is an ideal candidate for a new covered call today. Buying the stock for $60.50 while simultaneously selling the January $60.00 call will result in a new position with a target return of 5.4 %. Based on recent prices, this position will cost about $56.90, which is also the trade’s breakeven point. At that level, this covered call has 6.0 % downside protection, while still providing a 5.4 % return in 68 days as long as ENDP is above $60.00 on 1/18/2014. For comparison purposes only, this Endo Pharmaceuticals covered call aims for an annualized return rate of 29.2 %.

Nektar Therapeutics (NASDAQ: NKTR) has been selected by InvestorsObserver analysts as a stock that is an ideal candidate for a new covered call today. Buying the stock for $10.84 while simultaneously selling the May $9.00 call will result in a new position with a target return of 12.6 %. Based on recent prices, this position will cost about $7.99, which is also the trade’s breakeven point. At that level, this covered call has 26.3 % downside protection, while still providing a 12.6 % return in 187 days as long as NKTR is above $9.00 on 5/17/2014. For comparison purposes only, this Nektar Therapeutics covered call aims for an annualized return rate of 24.7 %.

Riverbed Technology (NASDAQ: RVBD) has been chosen by InvestorsObserver analysts as a candidate for a new covered call today. Selling the March $16.00 call while at the same time buying RVBD stock for $17.54 will produce a new covered call with a target return of 7.4 %. Based on recent data, this trade will cost about $14.90, which is also the covered call’s breakeven point. At that price, this covered call has 15.1 % downside protection, while seeking an assigned return of 7.4 % return in 131 days. If RVBD is higher than $16.00 on 3/22/2014, we are assured that simple return. For comparison purposes only, that equates to an annualized return rate of 20.6 %.

Ubiquiti Networks (NASDAQ: UBNT) has been selected by InvestorsObserver analysts as a stock that is a strong candidate for a new covered call today. Selling the December $39.00 call while simultaneously buying UBNT stock for $41.25 will result in a new position with a break-even point around $36.95. At that price, this position has a target return of 5.5 %. This trade has 10.4 % downside protection, while still providing a 5.5 % return in 40 days as long as UBNT is above $39.00 on 12/21/2013. For comparison purposes only, this Ubiquiti Networks covered call targets an annualized return rate of 50.6 %.

Check your email for a password to log into our site and read all our Essentials analysis. Add InvestorsObserver.com to your "Safe Senders" list to ensure you receive our messages.

Don't miss out on any vital trading information! Add Support@InvestorsObserver.com to your address book. View complete step-by-step instructions here.